Senti Bio
Professional Services · Biotechnology

Senti Bio news and milestones

Senti Bio: 18 headlines on record, 0 headlines in the last 90 days. Its story counts 4 milestones.

Data updated Nov 16, 2026 · Back to the company report
18Headlines
0In 90 days
4Milestones

Headlines

Mar 272026
Press release · The Manila Times
SOUTH SAN FRANCISCO, Calif., March 27, 2026 (GLOBE NEWSWIRE) -- Senti Biosciences, Inc. (Nasdaq: SNTI) (
Dec 8, 20252025
Blog
American Society of Hematology (ASH) Annual Meeting 2025Nosha Farhadfar, Stephen Strickland, Ashish Bajel, Alireza Eghtedar, Brian Garrison, Rochelle Emery, Kanya Rajangam, Gary…
Dec 8, 20252025
Nov 3, 20252025
Press release · The Globe and Mail
Detailed price information for Senti Biosciences Holdings Inc (SNTI-Q) from The Globe and Mail including charting and trades.
Jul 18, 20252025
Blog
Mr. Baum is a serial entrepreneur and investor and is the Co-Founder and Managing Partner of K5 Global. His portfolio includes category-defining companies such as SpaceX, xAI, An…
Apr 30, 20252025
Blog
AACR Annual MeetingMuharrem Muftuoglu, Mahesh Basyal, Li Li, Jiangxing Lv, Lauren Ostermann, Han Deng, Priscilla Wong, Timothy K. Lu, Brian S. Garrison, Kanya Rajangam, Michael A…
Apr 29, 20252025
Blog
AACR Annual MeetingMuharrem Muftuoglu, Enping Hong, Stephen A. Strickland, Alireza Eghtedar, Gary Schiller, Nosha Farhadfar, Ashish R. Bajel, Farhad Ravandi, Mahesh Basyal, Li Li…
Apr 28, 20252025
Press release · Nasdaq
--Senti Biosciences, Inc., a clinical-stage biotechnology company developing next-generation cell and gene therapies using its proprietary Gene Circuit platform, today reported a…
Apr 3, 20252025
News · SeekingAlpha
--Senti Biosciences, Inc., a clinical-stage biotechnology company developing next-generation cell and gene therapies using its proprietary Gene Circuit platform, today announced…
Mar 19, 20252025
Blog
Mr. Hsiung is the Founder, Chief Investment Officer, and Chief Executive Officer of Acion Partners, an investment advisor firm that has a strategic partnership with KKR and inves…
Mar 12, 20252025
Press release · The National Law Review
- Company also announced inducement grants under Nasdaq Listing Rule 5635(c)(4) - SOUTH SAN FRANCISCO, Calif., March 13, 2025 (GLOBE NEWSWIRE) -- Senti Biosciences
Feb 25, 20252025
Blog
Mr. Siddiqui brings over 27 years of biopharmaceutical experience with a proven track record in novel modalities and exceptional leadership to Senti, where he is responsible for…
Jan 7, 20252025
Blog
Mr. Tang is the Managing Partner of Celadon Partners, a private equity firm that he founded in 2018. From 2004 to 2017, Mr. Tang worked at D.E. Shaw & Co., most recently as chief…
Dec 2, 20242024
Blog
Ms. Schulz has served as a member of our board of directors since 2024. Ms. Schulz was one of the founding members and senior partners in Ernst & Young's (EY) Life Sciences Pract…
May 13, 20242024
Press release · Nasdaq
--Senti Biosciences, Inc., a biotechnology company developing next-generation cell and gene therapies using its proprietary Gene Circuit platform, today announced that patient do…
Apr 30, 20242024
News · Star Tribune
Your source for Minnesota news today. Read articles, view photos or watch videos about news in Minneapolis, St. Paul, Duluth, St. Cloud, Rochester, and beyond.
Sources: the outlets named on each headline, each story once

Milestones

Each milestone is dated by its source: registers, filings, the press

How to cite

Senti Bio, News. Alion, Nov 16, 2026. https://alion.io/company/sentibio/news

.json · .md · CC BY-SA 4.0